U.S. infectious disease company IPO financing 2006-2023
In 2023, R&D stage emerging infectious disease companies in the U.S. raised only eight million dollars by going public. This graph shows the amount of money companies active in infectious disease reserach in the U.S. raised through initial public offerings from 2006 to 2023.